Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes

Overview of attention for article published in Cardiovascular Diabetology, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Dimensions has found 63 publications that cite this research output.

Article in Expert Opinion on Drug Safety (November 2023)

Article in Frontiers in Pharmacology (November 2023)

Article in Cardiovascular Prevention and Pharmacotherapy (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.